Detalhe da pesquisa
1.
helixCAM: A platform for programmable cellular assembly in bacteria and human cells.
Cell
; 185(19): 3551-3567.e39, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055250
2.
Progress and limitations in engineering cellular adhesion for research and therapeutics.
Trends Cell Biol
; 34(4): 277-287, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37580241
3.
Measurement of large serine integrase enzymatic characteristics in HEK293 cells reveals variability and influence on downstream reporter expression.
FEBS J
; 288(22): 6410-6427, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34043859
4.
Laboratory-Generated DNA Can Cause Anomalous Pathogen Diagnostic Test Results.
Microbiol Spectr
; 9(2): e0031321, 2021 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34523989
5.
Telbivudine versus lamivudine in patients with chronic hepatitis B.
N Engl J Med
; 357(25): 2576-88, 2007 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18094378
6.
Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial.
Hepatology
; 47(2): 447-54, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18080339
7.
Absence of food effect on the pharmacokinetics of telbivudine following oral administration in healthy subjects.
J Clin Pharmacol
; 46(3): 275-81, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16490803
8.
Single-dose and multiple-dose pharmacokinetics and safety of telbivudine after oral administration in healthy Chinese subjects.
J Clin Pharmacol
; 46(9): 999-1007, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16920894
9.
Anomalous COVID-19 tests hinder researchers.
Science
; 371(6526): 244-245, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33446547
10.
Comparison of treatment with fluvastatin extended-release 80-mg tablets and immediate-release 40-mg capsules in patients with primary hypercholesterolemia.
Clin Ther
; 25(3): 904-18, 2003 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12852707
11.
Pharmacokinetics of telbivudine in subjects with various degrees of renal impairment.
Antimicrob Agents Chemother
; 51(12): 4231-5, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17875994
12.
Pharmacokinetics of telbivudine in healthy subjects and absence of drug interaction with lamivudine or adefovir dipivoxil.
Antimicrob Agents Chemother
; 50(7): 2309-15, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16801406
13.
Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection: pharmacodynamic implications.
Antimicrob Agents Chemother
; 50(3): 874-9, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16495245
14.
Pharmacokinetics of telbivudine in subjects with various degrees of hepatic impairment.
Antimicrob Agents Chemother
; 50(5): 1721-6, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16641441
15.
A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B.
Gastroenterology
; 129(2): 528-36, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16083710
16.
A dose-finding study of once-daily oral telbivudine in HBeAg-positive patients with chronic hepatitis B virus infection.
Hepatology
; 40(3): 719-26, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15349912